-transparent.png){kind=logo}
A possible interaction between fluvastatin, a new HMG CoA reductase inhibitor, and cyclosporin A (CsA) was studied in 16 stable renal transplant patients with dyslipoproteinemia despite dietary control. They entered a 12-week study period: 4-week baseline, 4-week placebo and 4-week fluvastatin treatment (20 mg daily). Weekly trough whole blood CsA concentrations were measured by monoclonal antibody immunoassay. Serial renal and liver function tests and creatine phosphokinase (CPK) were monitored. The mean trough levels of CsA during fluvastatin treatment were 115.6 micrograms/l compared with 114.3 micrograms/l and 113.3 micrograms/l in the baseline and placebo period, respectively. Apart from a small decrease in serum albumin level (from a mean of 38.6 g/l to 37.9 g/l), there were no significant changes in renal and liver functions or CPK levels. No adverse effects were reported. Fluvastatin (20 mg daily) may be used safely without extra monitoring of blood CsA concentrations in renal transplant patients.
P K Li, and
T W Mak, and
A Y Wang, and
Y T Lee, and
C B Leung, and
S F Lui, and
C W Lam, and
K N Lai
April 1989,
British journal of clinical pharmacology,
P K Li, and
T W Mak, and
A Y Wang, and
Y T Lee, and
C B Leung, and
S F Lui, and
C W Lam, and
K N Lai
October 1987,
Presse medicale (Paris, France : 1983),
P K Li, and
T W Mak, and
A Y Wang, and
Y T Lee, and
C B Leung, and
S F Lui, and
C W Lam, and
K N Lai
February 1989,
Presse medicale (Paris, France : 1983),
P K Li, and
T W Mak, and
A Y Wang, and
Y T Lee, and
C B Leung, and
S F Lui, and
C W Lam, and
K N Lai
December 1999,
Journal of clinical pharmacy and therapeutics,
P K Li, and
T W Mak, and
A Y Wang, and
Y T Lee, and
C B Leung, and
S F Lui, and
C W Lam, and
K N Lai
July 1999,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
P K Li, and
T W Mak, and
A Y Wang, and
Y T Lee, and
C B Leung, and
S F Lui, and
C W Lam, and
K N Lai
February 2003,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
P K Li, and
T W Mak, and
A Y Wang, and
Y T Lee, and
C B Leung, and
S F Lui, and
C W Lam, and
K N Lai
July 1998,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
P K Li, and
T W Mak, and
A Y Wang, and
Y T Lee, and
C B Leung, and
S F Lui, and
C W Lam, and
K N Lai
June 1989,
Australian and New Zealand journal of medicine,
P K Li, and
T W Mak, and
A Y Wang, and
Y T Lee, and
C B Leung, and
S F Lui, and
C W Lam, and
K N Lai
April 2006,
International journal of clinical pharmacology and therapeutics,
P K Li, and
T W Mak, and
A Y Wang, and
Y T Lee, and
C B Leung, and
S F Lui, and
C W Lam, and
K N Lai
September 1981,
Lancet (London, England),
